<DOC>
	<DOCNO>NCT01768208</DOCNO>
	<brief_summary>This study open-label , cohort study evaluate potential mechanism Saxagliptin treatment patient type 2 diabetes ( T2DM ) use comprehensive metabolomic method , combination fingerprint analysis target analysis . It sub-study STUDY : D168L00008 .</brief_summary>
	<brief_title>Metabolomic Variations Saxagliptin-Treated Type 2 Diabetes Mellitus Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<criteria>All subject Inclusion Criteria refer STUDY : D168L00008 . Briefly 1 . Provision inform consent prior study specific procedures 2 . Diagnosed type 2 diabetes 3 . Men woman 18 year age . 4 . Patients drug na√Øve treat metformin alone stable dos least continue 8 week . 5 . HbA1c 7.5 % 11.0 % All subject Exclusion Criteria refer STUDY : D168L00008 . Briefly 1 . Pregnant breastfeeding patient . 2 . Insulin therapy within one year enrolment ( exception insulin therapy hospitalization use gestational diabetes ) . 3 . Previous treatment dipeptidyl peptidaseIV ( DPPIV ) inhibitor Glucagonlike peptide1 ( GLP1 ) analogue . 4 . History administration antihyperglycemic therapy ( metformin ) 8 week prior Visit 1 ( 12 week previous TZD ) . 5 . Treatment systemic glucocorticoid replacement therapy . Inhaled , local inject topical use glucocorticoid allow . 6 . Treatment strong cytochrome P450 inhibitor . 7 . Gastrointestinal surgery could impact absorption study drug . 8 . Contraindications therapy outline saxagliptin package insert . 9 . Hypersensitivity saxagliptin 10 . Have history , currently , acute chronic pancreatitis . 11 . Type 1 diabetes , history diabetic ketoacidosis hyperosmolar nonketonic coma . 12 . Any condition , opinion investigator , participation study may pose significant risk patient could render patient unable successfully complete study . 13 . Fasting plasma glucose &gt; 15mmol/l .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>